Impact of 18F-FDG PET/CT Scan on Management of Non-small Cell Lung Cancer Patients in Contexts of University-Based Hospital in Thailand
Keywords:
Public Open Spaces, Use Patterns, Characteristics of Public Open Spaces, Trang Town’s commercial areasAbstract
Objective: To determine the impact of Fluorine-18 fluorodeoxy glucose (18F-FDG) positron emission tomography with computed tomography (PET/CT scan) on management of non-small cell lung cancer (NSCLC) in contexts
of university-based hospital in Thailand where most patients were in advanced disease and conventional imaging (CI) had previously been done.
Methods: Between December 2006 to December 2014, PET/CT scan and CI - e.g. chest and upper abdominal CT scan and bone scintigraphy of 120 pathologically proven NSCLC patients were independently reviewed. Stagings based
on CI and PET/CT scan were evaluated. Proposed treatment plan based on CI and given treatment based on PET/ CT scan were compared in patients whose medical records were available. Impact of PET/CT scan on management
was categorized into inter-modality and intra-modality treatment change – i.e. change in radiation fields.
Results: Of 120 NSCLC patients, PET/CT scans were performed for initial staging (INS) in 60 patients, posttreatment evaluation (PTE) in 41 patients and restaging at time of recurrence or progression (RR) in 19 patients.
PET/CT scan changed the disease status in 38 patients (31.7%). Changes to more advanced and less advanced disease were found in 26 patients (11 INS, 8 PTE and 7 RR patients) and 12 patients (3 INS, 6 PTE and 3 RR patients),
respectively. Among 83 patients with available proposed treatment plan, inter-modality treatment changes were observed in 19 patients (22.9%). Changes were more frequent in setting of PTE and RR (14/19 patients; 73.7%). The
most common changes were toward palliative chemotherapy (15/19 patients, 78.9%) owing to unexpected distant metastasis. Among 43 patients who received radiation therapy, changes in radiation approach were found in 18
patients (41.9%), mostly due to positive or negative lymph node (LN) metastasis.
Conclusion: PET/CT scan has considerable impact on staging and both inter-modality and intra-modality treatment change in NSCLC patients in all settings – INS, PTE and RR even with the presence of CI. Therefore, PET/CT scan
should be considered for staging and guiding the multidisciplinary treatment.
Downloads
Published
How to Cite
Issue
Section
License
Users are free to share, copy, and redistribute all articles published in the Siriraj Medical Journal (SMJ) in any medium or format as long as you follow the following terms:
- Attribution — You must give appropriate credit, provide a link to the material, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the publisher endorses you or your use.
- NonCommercial — You may not use the material for commercial purposes.
- NoDerivatives — If you remix, transform, or build upon the material, you may not distribute the modified material.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.